Search

ISSN: 2228-5881 eISSN: 2251-7308

Adv Pharm Bull. 2022;12(1): 5-6. doi: 10.34172/apb.2022.002

PMID: 35517893 PMCID: PMC9012925

Letter to Editor

Could Curcumin Modified Silver Nanoparticles Treat COVID-19?

Siukan Law ¹ * , Chuiman Lo ², Jie Han ¹, Albert Wingnang Leung ³, Chuanshan Xu ⁴

Cited by CrossRef: 0

1- Ahmadi S, Mohit M, Mehrabi Z, Heydari M, Faraji S, Yaghoubi S, Zare M, Masoumi S, Lidoriki E. The Effect of Nanocurcumin Supplementation on Inflammatory and Biochemical Indicators in Hospitalized Patients With COVID‐19: A Randomized Controlled Clinical Trial. International Journal of Clinical Practice. 2024;2024(1) [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank